Redmile Group LLC 13D and 13G filings for REGENXBIO Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-14 9:00 pm Purchase |
2024-09-30 | 13G | REGENXBIO Inc. RGNX |
Redmile Group LLC | 4,942,312 9.900% |
1,181,622![]() (+31.42%) |
Filing |
2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | REGENXBIO Inc. RGNX |
Redmile Group LLC | 3,760,690 8.600% |
-477,622![]() (-11.27%) |
Filing |
2023-11-17 5:15 pm Purchase |
2023-11-09 | 13G | REGENXBIO Inc. RGNX |
Redmile Group LLC | 4,238,312 9.600% |
2,341,089![]() (+123.40%) |
Filing |
2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | REGENXBIO Inc. RGNX |
Redmile Group LLC | 1,897,223 4.400% |
-226,269![]() (-10.66%) |
Filing |
2021-02-16 4:08 pm Sale |
2020-12-31 | 13G | REGENXBIO Inc. RGNX |
Redmile Group LLC | 2,123,492 5.700% |
-384,894![]() (-15.34%) |
Filing |